Leserbrief
When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds
Clinical Gastroenterology and Hepatology · 2026-07
DOI: 10.1016/j.cgh.2026.07.024 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-07. Verfasst von Changhong Miao. Beteiligte Einrichtung: Tianjin University of Traditional Chinese Medicine, Tianjin, China. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zitieren
APA
Miao, C. (2026). When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.07.024
Vancouver
Miao C. When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.07.024
BibTeX
@article{Miao2026,
author = {Miao, Changhong},
title = {When a Risk Marker Becomes a Treatment Indication: A Cautionary Note on Sex-Stratified Antiviral Thresholds},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.07.024}
}
EUVIMED